Latest News

BASIS CEO John McCahill at 2012 IMCAS
BASIS' A.J. Lloyd is Promoted to Executive Vice-President of Marketing & Communications
BASIS' Chantal Ward Promoted to Managing Director of Canadian Market

Events

BASIS Kicks Off Busy Trade Show Season with Partners at AAD
BASIS to Attend American Society of Plastic Surgery Meeting

Biretix’ novel patented RetinSphere complex provides the benefits of a retinoid with significantly less irritation.

A cosmeceutical, BiRetix offers tolerable, broad spectrum action against acne, including:
-Accelerated cellular turnover
-Normalization of hyperkeratinization
-Reduction of inflammation

Unlike traditional retinoids, BiRetix is encapsulated in a biomimetic glycosphere. This exclusive technology, known as RetinSphere, gradually releases the retinoid in order to minimize irritation and enhance the formulation’s stability.  Combined with a non-irritating alternative to alpha-hydroxy acids, RetinSphere offers a totally new approach to acne that is tolerable, effective and safe to use even during summer months.